Back PainNCT07892066
Comparative Effects of Soft Tissue Mobilization and Pressure Therapy With and Without Dynamic Cupping on on Pain and Disability in Patients With Thoracic Back Pain.
A study testing Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Directional dynamic cupping in people with Back Pain, run by University of Management and Technology Lahore at 1 site in Pakistan.
Trial summary
This study aims to compare the sequential effects of Instrument-Assisted Soft Tissue Mobilization (IASTM) and Transverse Oscillatory Pressure (TOP), with and without Directional Dynamic Cupping, in patients with thoracic back pain. Read more about this study
- Who is it for?
- Ages 25 to 45 years
- Conditions the study is for
- Back Pain
- What is being tested?
- Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Directional dynamic cupping
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 64 participants
- Where
- 1 sitePakistan
- Study dates
- 20 Oct 2026to 31 Dec 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Non-specific chronic thoracic back pain patients aged between 25 to 45 Both genders. Mild to moderate thoracic back pain with NPRS pain score value of between 3/10 6/10. Pain from at least past three months (12 weeks). Pain localized to thoracic region T1-T12, no radiating pain Willing to provide informed consent and attend all sessions
Who cannot join
- Pathological conditions or diagnosed with disk herniation, spinal stenosis, spondylolisthesis, and spondylitis and other medical illnesses such as tumor, lungs disease, and visceral disease or any other red flag condition Referred pain: cervical/lumbar radiculopathy History of cardio-respiratory disease, thoracic surgery, or ribs fracture fixation surgery <6 months Bleeding disorder/anticoagulant use, skin infection, hypersensitivity at treatment area Pregnancy, BMI >35.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site
University of Management & Technology
Lahore, Punjab Province, 54000
About this study
Official title: Comparison of Sequential Effects of Instrument Assisted Soft Tissue Mobilization and Transverse Oscillatory Pressure With and Without Directional Dynamic Cupping on Pain and Disability in Patients With Thoracic Back Pain.
This study aims to compare the sequential effects of Instrument-Assisted Soft Tissue Mobilization (IASTM) and Transverse Oscillatory Pressure (TOP), with and without Directional Dynamic Cupping, in patients with thoracic back pain. The study will evaluate the effectiveness of these treatment approaches in reducing pain, improving functional ability, and minimizing disability during daily activities.
- Conditions
- Back Pain
- Being tested
- Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP), Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Directional dynamic cupping
- Keywords
- Instrument-assisted soft tissue mobilization, Manual therapy, Functional disability, Directional dynamic cupping, Transverse oscillatory pressure
- Medical subject headings
- Back Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP)Other
Participants will receive Instrument-Assisted Soft Tissue Mobilization (IASTM) and Transverse Oscillatory Pressure (TOP) in sitting or prone positions, combined with alternating 10-second resisted isometric trunk flexion-extension contractions. Conventional therapy includes a hot pack for 10 minutes and muscle stretching (10 repetitions, 30-second hold each).
Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Directional dynamic cuppingOther
Participants will receive a moist hot pack over the thoracic region for 10-15 minutes, followed by IASTM using the Graston tool for 5-8 minutes.
Transverse Oscillatory Pressure (TOP) will be applied for 3-5 minutes per affected segment, according to patient tolerance.
Directional Dynamic Cupping will then be performed over the thoracic paraspinal muscles for 5-10 minutes with controlled suction and gliding movements.
| Study group | Role | What they receive |
|---|---|---|
| Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) | Active comparator | Not described Receives: Other: Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) |
| Instrument assisted soft tissue, Transvers oscillatory pressure and Directional dynamic cupping | Experimental | Not described Receives: Other: Instrument assisted soft tissue (IASTM), Transvers oscillatory pressure (TOP) and Directional dynamic cupping |
What is being measured
The primary outcome is the main question the study is designed to answer.
Numerical Pain Rating Scale
The 11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADLs).
Measured: Baseline , after 2 weeks and 4 weeks post treatment
FUNCTION RATING INDEX
The Functional Rating Index (FRI) consists of 10 items: pain intensity, pain frequency, sleep, personal care, travel, work, leisure activities, lifting, walking, and standing. Two items assess pain characteristics, while eight assess spinal functional limitations in daily activities. Each item is scored from 0 (no pain/full function) to 4 (maximum pain/total disability), with higher scores indicating greater disability.
Measured: Baseline , after 2 weeks and 4 weeks post treatment
BUBBLE INCLINOMETER
Lumbar range of motion (ROM) will be measured in standing using bubble inclinometers, with S1 and T12 as reference points for flexion and extension, and T12 for lateral flexion.
Two inclinometers will assess forward flexion, while one will assess extension and lateral flexion; actual flexion and extension ROM will be calculated by subtracting the lower inclinometer reading from the upper reading.
Measured: Baseline , after 2 weeks and 4 weeks post treatment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2026
- Study start20 Oct 2026 (estimated)
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Back PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 64 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Management and Technology Lahore
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Salman Bashir, University of Management and Technology Lahore
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07892066
- Sponsor's protocol ID
- RE-166-2026
- Status last verified
- Oct 2026
- First submitted
- 17 Oct 2026
- Last updated
- 23 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The result data collected de-identified individual participant data will be shared.